(NXE) NexGen Energy - Overview
Stock: Uranium, Exploration, Development, Properties
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 58.0% |
| Relative Tail Risk | -8.58% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.16 |
| Alpha | 49.48 |
| Character TTM | |
|---|---|
| Beta | 1.274 |
| Beta Downside | 1.040 |
| Drawdowns 3y | |
|---|---|
| Max DD | 54.28% |
| CAGR/Max DD | 0.61 |
Description: NXE NexGen Energy January 10, 2026
NexGen Energy Ltd. (NYSE: NXE) is a Vancouver-based, exploration-stage firm focused exclusively on uranium. It owns 100 % of the Rook I project in Saskatchewan’s southwestern Athabasca Basin, covering roughly 35,065 ha across 32 contiguous mineral claims. The company was incorporated in 2011 and remains in the development phase, with no commercial production yet.
Key metrics (as of the most recent public filings) include an inferred resource of approximately 70 Mt of uranium oxide (≈ 1.2 Mt U₃O₈) at Rook I, a cash balance of C$ 150 million, and a drilling program targeting a 2025 pre-feasibility study. The primary economic driver is the long-term uranium price outlook, which is currently supported by rising global nuclear capacity targets (e.g., the IAEA’s forecast of a 30 % increase in nuclear generation by 2040) and a tightening supply gap as legacy mines retire.
Given the high-grade nature of the Athabasca Basin and NexGen’s relatively low-cost development plan, the upside potential hinges on confirming resource continuity and securing financing under a higher uranium price environment; a sustained price below US $30/lb would materially impair the project’s economics.
For a deeper, data-driven look at NexGen’s valuation assumptions, the ValueRay platform offers a transparent model you might find useful.
Piotroski VR‑10 (Strict, 0-10) 1.0
| Net Income: error (cannot be calculated; needs Net Income TTM and Revenue TTM) |
| FCF/TA: -0.18 > 0.02 and ΔFCF/TA -13.59 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA -0.02 > 3% & CFO -32.0m > Net Income -333.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.50 > 1.5 & < 3 |
| Outstanding Shares: last quarter (573.1m) vs 12m ago -6.63% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 0.0% > 50% (prev 0.0%; Δ 0.0% > 0%) |
| Interest Coverage Ratio: -5.87 > 6 (EBITDA TTM -270.3m / Interest Expense TTM 46.4m) |
Altman Z'' -4.87
| A: -0.20 (Total Current Assets 317.9m - Total Current Liabilities 637.9m) / Total Assets 1.57b |
| B: -0.41 (Retained Earnings -648.4m / Total Assets 1.57b) |
| C: -0.17 (EBIT TTM -272.6m / Avg Total Assets 1.62b) |
| D: -1.00 (Book Value of Equity -648.4m / Total Liabilities 647.4m) |
| Altman-Z'' Score: -4.87 = D |
What is the price of NXE shares?
Over the past week, the price has changed by -12.17%, over one month by +1.10%, over three months by +35.79% and over the past year by +71.16%.
Is NXE a buy, sell or hold?
What are the forecasts/targets for the NXE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 5.3 | -51.9% |
| Analysts Target Price | 5.3 | -51.9% |
| ValueRay Target Price | 14.7 | 33.2% |
NXE Fundamental Data Overview February 03, 2026
P/B = 12.8895
Revenue TTM = 0.0 CAD
EBIT TTM = -272.6m CAD
EBITDA TTM = -270.3m CAD
Long Term Debt = 437.0k CAD (from capitalLeaseObligations, last quarter)
Short Term Debt = 592.3m CAD (from shortLongTermDebt, last quarter)
Debt = 456.8m CAD (from shortLongTermDebtTotal, last fiscal year)
Net Debt = 286.3m CAD (from netDebt column, last quarter)
Enterprise Value = 11.39b CAD (11.24b + Debt 456.8m - CCE 306.0m)
Interest Coverage Ratio = -5.87 (Ebit TTM -272.6m / Interest Expense TTM 46.4m)
EV/FCF = -40.61x (Enterprise Value 11.39b / FCF TTM -280.5m)
FCF Yield = -2.46% (FCF TTM -280.5m / Enterprise Value 11.39b)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 7.27 (Enterprise Value 11.39b / Total Assets 1.57b)
Interest Expense / Debt = 2.47% (Interest Expense 11.3m / Debt 456.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -215.3m (EBIT -272.6m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.50 (Total Current Assets 317.9m / Total Current Liabilities 637.9m)
Debt / Equity = 0.50 (Debt 456.8m / totalStockholderEquity, last quarter 918.8m)
Debt / EBITDA = -1.06 (negative EBITDA) (Net Debt 286.3m / EBITDA -270.3m)
Debt / FCF = -1.02 (negative FCF - burning cash) (Net Debt 286.3m / FCF TTM -280.5m)
Total Stockholder Equity = 1.06b (last 4 quarters mean from totalStockholderEquity)
RoA = -20.51% (Net Income -333.2m / Total Assets 1.57b)
RoE = -31.53% (Net Income TTM -333.2m / Total Stockholder Equity 1.06b)
RoCE = -25.78% (EBIT -272.6m / Capital Employed (Equity 1.06b + L.T.Debt 437.0k))
RoIC = -13.92% (negative operating profit) (NOPAT -215.3m / Invested Capital 1.55b)
WACC = 10.27% (E(11.24b)/V(11.70b) * Re(10.61%) + D(456.8m)/V(11.70b) * Rd(2.47%) * (1-Tc(0.21)))
Discount Rate = 10.61% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 4.45%
Fair Price DCF = unknown (Cash Flow -280.5m)
EPS Correlation: -54.85 | EPS CAGR: -58.77% | SUE: -3.05 | # QB: 0
Revenue Correlation: N/A | Revenue CAGR: 0.0% | SUE: 0.0 | # QB: 0